Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Baikuirui is an antibiotic resistance biosynthesis developing company.
Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.
Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.
Brattea is a medical device research and development company.
Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses.
Revolutionizing Arrhythmia Care
Artheia is a cutting-edge medical device firm that specializes in ophthalmology and offers a diverse product line.
Health Outlook use modern proteomics to better predict health events and improve health outcomes.
Chuanxin Biotech is an RNA drug research and development service provider.
Heranova is developing innovative diagnostics and treatments designed to improve women's health and address reproductive challenges
Changsha Morning Shine is a pharmaceutical company that specializes in developing CDMO services, chemical drugs and biotechnology services.
Innovo Therapeutics is a anti-cancer drug developer committed to research and creation of medications that target protein breakdown.
Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.
Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
Huili Pharmaceutical is a drug delivery platform that specializes in the development of nanoparticles and microsphere preparation equipment.
Imagine Pharma is a drug discovery and development company that offers a platform to provide therapeutic and regenerative medicine.
Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.
Ligatech Bioscience is an intrusive consumables developer .
AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.
Eluminex Biosciences is dedicated to the research and commercialization of novel therapies to address unmet medical needs.
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases, as well as chronic disease.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
BioVenture has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Medical, Health Care, Biotechnology, Biopharma, Medical Device. The firm invests across 18 different industry categories.
Among tracked funding rounds, varnotech received $83.0M in a Series B round. BioVenture's total known invested capital is $2.1B.
BioVenture's average investment size is $23.9M across its portfolio of 279 companies.
Recent BioVenture portfolio additions include Baikuirui, Rallybio, Neurosterix, Brattea, varnotech. These companies were founded in 2020 or later.